Company at a Glance

Sialo Technology Ltd. provides medical solutions for the treatment of salivary gland diseases and other oral conditions. Sialo’s flagship technology, salivary gland endoscopy, provides an accurate means of diagnosing and locating oral obstructions, such as salivary gland stones, and permits minimally invasive oral surgical procedures.
The company’s most exciting development – root canal endoscopy – is expected to have a significant impact on the dental market
Sialo was founded in Oct. 2002 and is a public company on TASE (SALO) since Feb. 2007

Technology & Product(s)

Sialo’s endoscope solutions are marketed globally and allow doctors to perform minimally invasive procedures in their clinics in cases that previously required full surgery and gland removal. The company offers drains and balloons for use on salivary glands; Lithotripter, an extracorporeal shock wave therapy treatment for salivary gland disorders; and Salivascope, an endoscope system for the treatment of salivary glands.
Sialo Technology offers a full product line of FDA approved disposable items — drains, balloons and baskets — used with advanced endoscopic techniques. Sialo also markets high quality, compact lithotriptors, both with and without an ultrasound unit, for breaking stones into small pieces.
The company’s most exciting development – root canal endoscopy – is expected to have a significant impact on the dental market. Sialo offers a tiny endoscope to enable improved visibility of the area under treatment, thereby markedly increasing the success rate of root canal procedures and preventing secondary complications. Potential applications include the detection of throat and mouth cancer.

Goal

Objectives: Completion of FDA approval and beginning worldwide marketing by cooperation with worldwide distributers.
Target businesses: Worldwide distributers.
Target Countries: Worldwide